'I went from being a very active person to barely being able to stand without getting so acutely dizzy.'
CBS 2's Jermont Terry shows us, a Wheaton woman opens up about the lasting impact, as Northwestern Medicine reveals the finding of its study.
"I went from being a very active person to barely being able to stand for five minutes without getting so acutely dizzy. Having zero standing tolerance." "I'd say I'm 90 to 95% better, but there are still definitely some symptoms that linger," Caffee said. *Experience neurologic symptoms, fatigue, and compromised quality of life 11-18 months after disease onset that continued for an average of 15 months. "There was a neutral affect. It didn't cure long COVID or make long COVID worse so we continue to encourage people to get vaccinated and boosted," said Dr. Igor Koralnik, Chief of neuro-infectious diseases at Northwestern Medicine.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced this morning.
Lire la suite »
Biden: Monkeypox threat doesn’t rise to level of COVID-19President Joe Biden is seeking to calm concerns about recent cases of monkeypox that have been identified in Europe and the United States.
Lire la suite »
COVID made nursing school in S.A. more real — and even more urgent‘Like they were soldiers:’ In San Antonio, pandemic shaped nurse training, expectations and jobs
Lire la suite »
Pfizer Announces Dosage Of COVID Shots For Children Under 5Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week.
Lire la suite »
Pfizer says 3 COVID shots protect children under 5Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in…
Lire la suite »
Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
Lire la suite »